KLOW
KLOW is a multi-peptide blend designed to support tissue repair, recovery, and skin regeneration. Each vial contains a total of 80 mg, made up of:
• TB-500 (10 mg)
• BPC-157 (10 mg)
• KPV (10 mg)
• GHK-Cu (50 mg)
What each peptide contributes:
TB-500
Supports wound healing, blood vessel formation, and overall tissue repair. It’s widely studied for helping muscles, tendons, and connective tissue recover from stress or injury.
BPC-157
Known for its regenerative properties, BPC-157 is researched for healing tendons, ligaments, muscles, and the gut lining. It’s commonly associated with faster recovery and reduced inflammation.
KPV
A short anti-inflammatory peptide that helps regulate inflammatory signaling in the body. It’s often studied for calming tissue irritation and supporting immune balance.
GHK-Cu (Copper Peptide)
Plays a major role in collagen production, skin repair, and cellular regeneration. It’s well known in research for improving skin quality, wound healing, and overall tissue health.
Common Research Uses
- Supporting tissue repair and recovery
- Skin quality and elasticity research
- Wound and inflammation response studies
- Cellular regeneration support
- Post-injury recovery research
Typical Research Dosing
Subcutaneous Protocol (80 mg + 3 mL BAC = 26.7 mg/mL)
| Phase | Daily Dose (mg) | Units per Injection |
|---|---|---|
| Weeks 1-2 (Tolerance) | TB-500: 250 mcg • BPC-157: 250 mcg • KPV: 250 mcg • GHK-Cu: 1.25 mg | 7.5 units |
| Weeks 3-4 (Build Phase) | TB-500: 500 mcg • BPC-157: 500 mcg • KPV: 500 mcg • GHK-Cu: 2.5 mg | 15 units |
| Weeks 5–8 (Peak Phase) | TB-500: 750 mcg • BPC-157: 750 mcg • KPV: 750 mcg • GHK-Cu: 3.75 mg | 22.5 units |
| Weeks 9–12 (Maintenance) | TB-500: 500 mcg • BPC-157: 500 mcg • KPV: 500 mcg • GHK-Cu: 2.5 mg | 15 units |
Based on reconstitution of 5 mg with 2 mL bacteriostatic water (2.5 mg/mL).
Reconstitution Steps
- Prep clean: Wash hands, use a clean surface, and gather supplies.
- Sanitize: Alcohol swab vial stoppers and allow to air-dry.
- Add diluent slowly: Inject bacteriostatic water down the vial wall to reduce foaming.
- Mix gently: Gently swirl or roll until fully dissolved. Do not shake.
- Label: Write compound name, date, and concentration (mg/mL).
- Store appropriately: Store according to supplier guidance and maintain sterile technique.
Educational reference only
Injection Technique
General subcutaneous guidance from clinical best-practice resources.
- Allow the peptide to reach room temperature before injection.
- Clean the vial stopper and injection site with alcohol and allow to fully dry.
- Pinch a small skinfold and insert the needle at a 45–90° angle into subcutaneous tissue.
- Do not aspirate for subcutaneous injections; inject slowly and steadily.
- Rotate injection sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
- Inject slowly to help minimize any stinging sensation.
This information is provided for educational reference only and reflects general clinical best practices.
Supplies Needed (Auto Calculator)
Inventory planning tool. Choose presets or enter your own values.
Notes: Syringes = (weeks × 7 × injections/day). Swabs = (syringes × swabs/injection). BAC = (vials × mL per vial). Bottles/boxes are rounded up.
Recommended Source
We recommend MADDOG Peps for high-purity KLOW (80 mg).
- High-purity lots with manufacturer-issued third-party COAs available upon request for transparency and quality reference.
- Consistent handling practices aligned with quality control standards.
- Reliable fulfillment, careful packaging, and fast UPS shipping to help maintain product integrity.
How It Works
KLOW combines peptides that interact with natural healing pathways in the body. These peptides are studied for their ability to signal tissue repair, reduce inflammatory responses, and support collagen and cellular regeneration.
Together, they may help the body recover more efficiently from physical stress or injury while also supporting healthier skin structure and repair processes.
Commonly Reported Side Effects
- Mild Headache
- Fatigue
- Nausea
- Injection site reactions
These effects are based on commonly reported research observations and may vary by individual.
